期刊文献+

微管异常在心肌病发生中的作用机制

Microtubule abnormalities in the pathogenesis of cardiomyopathy
原文传递
导出
摘要 微管是由微管蛋白二聚体构成的中空管状结构。微管蛋白二聚体是微管的基本结构,由仪、β-微管蛋白亚基头尾相连交替螺旋状排列而形成。微管大量存在于真核细胞的胞质中。微管作为一种细胞骨架的重要组成成份,参与细胞的多种活动,包括细胞形态的维持、胞内转运、纺锤体的形成、调节细胞的极性和参与鞭毛形成等。有多篇文献报道微管蛋白的修饰异常及微管相关蛋白调节异常均会引起微管的稳定性失衡。有文献报道微管稳定性的改变可能与心肌肥大、杜兴肌营养不良性心肌病、糖尿病心肌病的发生有关,但微管异常导致心肌病发生的具体机制尚不清楚。该文结合最新的研究成果,对微管异常导致心肌病的发生机制作一综述。 Microtubules are dynamic hollow tubes mainly found in the cytoplasm of eukaryotic cells. Tubulin heterodimers, the basic structures of microtubules, are assembled by β-tubulin subunits from head-to- tail and spirally. Microtubules are cytoskeletal structures that play an essential role in maintaining cell physiologi- cal function, including cell shape maintaining, intracellular transport, formation of mitotic spindle, modulating cell polarity, formation of flagellum and so forth. Moreover, the stability of microtubule structure is modulated by tubulin modifications and microtubule-associated proteins, and the dynamic modulation plays a fundamental role in myocardial hypertrophy, Duchenne muscular dystrophy(DMD) and diabetic cardiomyopathy. However, the molecular mechanism of microtubule in the pathogenesis of cardiomyopathy remains unclear. Here, the latest re- search and the molecular mechanism are reviewed.
作者 周元琳 吕铁伟 Zhou Yuanlin;Lyu Tiewei(Children's Hospital of Chongqing Medical University, Chongqing 400014, China)
出处 《国际儿科学杂志》 2017年第12期826-830,共5页 International Journal of Pediatrics
基金 国家自然科学基金(81570218) 重庆市卫生计委医学科研计划项目(20141009)
关键词 微管 微管相关蛋白 心肌病 机制 Microtubule Microtubule-associated protein Cardiomyopathy Mechanism
  • 相关文献

参考文献9

二级参考文献188

  • 1时惠平,于梅艳.心肌疾病的磁共振成像诊断[J].中华临床医师杂志(电子版),2011,5(23):6871-6875. 被引量:4
  • 2徐国恒.细胞骨架——肌动蛋白纤维[J].生物学通报,2005,40(2):43-43. 被引量:11
  • 3王虎,惠汝太.基因突变与扩张型心肌病[J].中华心血管病杂志,2006,34(3):193-195. 被引量:28
  • 4陈兰英,唐剑,许东辉,牛竞文,李祺福.环六亚甲基双乙酰胺诱导人肝癌SMMC-7721细胞分化过程中核基质-中间纤维系统的构型变化[J].电子显微学报,2007,26(3):212-216. 被引量:4
  • 5汪堃仁 薛绍白.细胞生物学[M].北京:北京师范大学出版社,1990..
  • 6Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee;Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups;and Council on Epidemiology and Prevention[J].Circ J,2006,113(14):1807-1816.
  • 7Richardson P,Mekenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of cardiology task force on the definition and classification of cardiomyopathy[J].Circ J,1996,93(5):841-842.
  • 8Elliott P,Andersson B,Arbustini E,et al.Classification of the cardiomyopathies:a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Disease[J].Eur Heart J,2008,29(2):270-272.
  • 9Lipshultz SE,Sleeper LA,Towbin JA,et al.The incidence of pediatric cardiomyopathy in two regions of the united states[J].N Engl J Med,2003,348(17):1647-1655.
  • 10Matsumori A,Furukawa Y,Hasegawa K,et al.Epide-miologic and clinical characteristics of cardiomyopathies in Japan results from nationwide surveys[J].Circ J,2002,66(4):323-336.

共引文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部